Changes in US stocks | Brain Regeneration Technology (RGC.US) continued to rise by more than 29% in two trading days, rising nearly 400%

Zhitongcaijing · 06/17 15:17

The Zhitong Finance App learned that on Tuesday, Brain Regeneration Technology (RGC.US) continued to rise by more than 29%, rising nearly 400% over two trading days to $77.30. According to the news, previously on May 9, Brain Regeneration Technology announced that its next-generation neuromodulation chip has passed FDA clinical trial approval and will cooperate with the world's top medical institution Mayo Clinic to conduct research on the treatment of Parkinson's disease.

Furthermore, the company recently announced a 38-1 stock split. The share distribution is scheduled for June 13, 2025, and the post-split transaction is scheduled to take place on June 16, 2025. The purpose of a stock split is to enhance the liquidity of a company's common stock in the market and make shares more accessible to investors.